Multinational pharmaceutical companies analyzed that they would not receive greater benefit from certification business of innovative pharmaceutical company

Published: 2014-06-18 15:18:41

Updated: 2014-06-18 15:18:41

Recently, 20 pharmaceutical companies submitted application for the second certification business of innovative pharmaceutical company. Among them, the number of multinational pharmaceutical company was only 5 companies including Novartis, Sanofi-Aventis Korea, AstraZeneca, Roche, and Boehringer Ingelheim.

An official from the company which renounced innovative certification said that "The bus...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.